CAMSAP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 9.16460000000008E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
9.83657599817889E-12 |
Normal-vs-Stage2 |
4.681600E-02 |
Normal-vs-Stage3 |
1.731000E-01 |
Normal-vs-Stage4 |
8.824000E-01 |
Stage1-vs-Stage2 |
2.596400E-02 |
Stage1-vs-Stage3 |
2.75210000000303E-06 |
Stage1-vs-Stage4 |
4.97169999946756E-07 |
Stage2-vs-Stage3 |
2.833000E-01 |
Stage2-vs-Stage4 |
7.830300E-02 |
Stage3-vs-Stage4 |
3.246200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.66762999999071E-05 |
Normal-vs-AfricanAmerican |
2.281300E-03 |
Normal-vs-Asian |
2.592100E-02 |
Caucasian-vs-AfricanAmerican |
2.323000E-01 |
Caucasian-vs-Asian |
9.892300E-02 |
AfricanAmerican-vs-Asian |
3.362800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.01310000000188E-05 |
Normal-vs-Female |
1.49709999996972E-06 |
Male-vs-Female |
2.388200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.508400E-02 |
Normal-vs-Age(41-60Yrs) |
1.37089999996398E-06 |
Normal-vs-Age(61-80Yrs) |
3.156000E-04 |
Normal-vs-Age(81-100Yrs) |
3.262000E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.388200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.355400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.170000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.761250E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.467200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.653000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.574700E-04 |
Normal-vs-Grade 2 |
6.59210463993531E-11 |
Normal-vs-Grade 3 |
5.444900E-03 |
Normal-vs-Grade 4 |
4.152800E-01 |
Grade 1-vs-Grade 2 |
2.925900E-02 |
Grade 1-vs-Grade 3 |
9.92140000000141E-05 |
Grade 1-vs-Grade 4 |
3.04890000024649E-07 |
Grade 2-vs-Grade 3 |
6.25209999999266E-05 |
Grade 2-vs-Grade 4 |
3.20430004752126E-09 |
Grade 3-vs-Grade 4 |
3.896500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.85327317328665E-14 |
Normal-vs-ccB subtype |
1.065810E-01 |
ccA subtype-vs-ccB subtype |
6.69629995897481E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.780960E-04 |
Normal-vs-N1 |
6.233200E-01 |
N0-vs-N1 |
3.692400E-01 |
|
|